Global fluorescence guided surgery (FGS) system market is anticipated to grow at a CAGR of 15.7% during the forecast period (2024-2031). The growing demand for minimal invasive surgical procedures is a key factor driving demand for the FGS systems. By using these systems, surgeons can do minimally invasive treatments with greater accuracy and cause less harm to healthy tissue to provide better patient outcomes. Demand for FGS technology is rising with clinical trials showing better surgical outcomes, lower positive margin rates, and lower recurrence rates. The commercialization and broad use of fluorescence-guided surgery systems have been expedited by FDA clearances, enabling companies to provide integrated intraoperative visualization.
Browse the full report description of “Fluorescence Guided Surgery System Market Size, Share & Trends Analysis Report by Type (SPY System, PDE System, and VS3 Iridium Systems), by Surgery (Open Surgery, and Laparoscopy/Endoscopy), and by Application (Cancer Surgeries, Cardiovascular Surgeries, and Others) Forecast Period (2024-2031)” at https://www.omrglobal.com/industry-reports/fluorescence-guided-surgery-system-market
Recent Developments-
In January 2024, Leica Microsystems has launched an evolved version of its ARveo 8 digital visualization microscope for neurosurgery. The ever-growing ecosystem, ARveo 8, enhances surgical visualization through the application of a 3D view and augmented reality (AR) fluorescence, as stated in a press release. For brain-tumor surgery, GLOW400 3D AR fluorescence support surgeons to achieve clear visualization of both anatomical structures and a wide range of fluorescence information. And, in vascular surgery, operators can now visualize fluorescent vascular flow in 3D with the GLOW800 AR fluorescence.
In September 2022, Olympus Corp. announced the launch of VISERA ELITE III, which is a surgical visualization platform that addresses the needs of healthcare professionals (HCPs) for endoscopic procedures across multiple medical disciplines. VISERA ELITE III offers various imaging functions, all supported in one system enabling minimally invasive therapies such as laparoscopic colectomy and laparoscopic cholecystectomy.
Market Coverage
• The market number available for – 2023-2031
• Base year- 2023
• Forecast period- 2024-2031
• Segment Covered-
o By Type
o By Surgery
o By Application
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- Hamamatsu Photonics K.K., Olympus Corp., Stryker Corp., Medtronic PLC, and Getinge AB, among others.
Key questions addressed by the report.
Global Fluorescence Guided Surgery System Market Report Segment
By Type
By Surgery
By Application
Global Fluorescence Guided Surgery System Market Report Segment by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/fluorescence-guided-surgery-system-market